Anti-TNFSF13 / APRIL / CD256 (BION-1301), 1mg*25

Anti-TNFSF13 / APRIL / CD256 (BION-1301), 1mg*25

Enoblituzumab (Anti-B7-H3 / CD276), 1mg*5

Enoblituzumab (Anti-B7-H3 / CD276), 1mg*5

Enoblituzumab (Anti-B7-H3 / CD276), 1mg

2.614,43 RON
SKU
SKM_A2626_1mg

Enoblituzumab (Anti-B7-H3 / CD276) is a humanized IgG1κ monoclonal antibody targeting human B7-H3 protein. It can be used in the treatment of medullary thyroid cancer (MTC). MW :150 KD.

Mai multe informatii
Price 2.197,00 RON (preturile sunt fara TVA)
Description

Enoblituzumab (Anti-B7-H3 / CD276) is a humanized IgG1κ monoclonal antibody targeting human B7-H3 protein. It can be used in the treatment of medullary thyroid cancer (MTC). MW :150 KD.